Drug Shortage Report for MYLAN-BECLO AQ

Last updated on 2019-03-09 History
Report ID 14271
Drug Identification Number 02172712
Brand name MYLAN-BECLO AQ
Common or Proper name BECLO AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BECLOMETHASONE DIPROPIONATE
Strength(s) 50MCG
Dosage form(s) METERED-DOSE AEROSOL SUSPENSION
Route of administration NASAL
Packaging size 22s
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-11-07
Actual start date 2018-11-07
Estimated end date 2019-02-28
Actual end date 2019-03-08
Shortage status Resolved
Updated date 2019-03-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v44 2018-01-18 English Compare
v43 2018-01-18 English Compare
v42 2018-01-17 French Compare
v41 2018-01-17 English Compare
v40 2018-01-15 French Compare
v39 2018-01-15 English Compare
v38 2018-01-12 French Compare
v37 2018-01-12 English Compare
v36 2018-01-11 French Compare
v35 2018-01-11 English Compare
v34 2018-01-11 English Compare
v33 2018-01-10 French Compare
v32 2018-01-10 English Compare
v31 2018-01-02 French Compare
v30 2018-01-02 English Compare
v29 2017-12-20 French Compare
v28 2017-12-20 English Compare
v27 2017-12-19 English Compare
v26 2017-12-18 French Compare
v25 2017-12-18 English Compare

Showing 41 to 60 of 84